Eric Venker

Eric Venker

President and Immunovant CEOatRoivant Sciences· In proxies 2020–2024

Pay in FY2024+1,767% from the year before · Roivant Sciences stock +42.8% the same year

Eric Venker was paid $11.8M in FY2024 (Mar), up 1,767%. Roivant Sciences stock rose 42.8% that year.

Pay$100 in the stock at the end of FY22 → $213
Pay is from the Summary Compensation Table of each Roivant Sciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Roivant SciencesPublic company · 6 yr
    • President and Immunovant CEO2020 – Present · 6 yrStock in role +356%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?